V67A logo

Cosmos Health DB:V67A Stock Report

Last Price

€0.39

Market Cap

€10.7m

7D

9.2%

1Y

-37.1%

Updated

07 May, 2025

Data

Company Financials

Cosmos Health Inc.

DB:V67A Stock Report

Market Cap: €10.7m

V67A Stock Overview

Manufactures, develops, and trades branded nutraceutical products in Greece, the United States, Croatia, Bulgaria, Ireland, the Cayman Islands, the UAE, the United Kingdom, and Cyprus. More details

V67A fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Risk Analysis

Highly volatile share price over the past 3 months compared to the German market

Earnings have declined by 38.7% per year over past 5 years

Has less than 1 year of cash runway

Shareholders have been substantially diluted in the past year

+ 1 more risk

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Cosmos Health Inc. Competitors

Arzneiwerk VIDA

XTRA:TLIK

€3.8m

Medios

XTRA:ILM1

€311.2m

Gesundheitswelt Chiemgau

MUN:JTH

€24.2m

AS Latvijas Juras medicinas centrs

MUN:UOM

€4.8m

Price History & Performance

Summary of share price highs, lows and changes for Cosmos Health
Historical stock prices
Current Share PriceUS$0.39
52 Week HighUS$1.32
52 Week LowUS$0.27
Beta4.3
1 Month Change28.59%
3 Month Change-42.27%
1 Year Change-37.05%
3 Year Changen/a
5 Year Changen/a
Change since IPO-97.90%

Recent News & Updates

Recent updates

Shareholder Returns

V67ADE HealthcareDE Market
7D9.2%5.6%2.5%
1Y-37.1%39.7%13.4%

Return vs Industry: V67A underperformed the German Healthcare industry which returned 39.7% over the past year.

Return vs Market: V67A underperformed the German Market which returned 13.4% over the past year.

Price Volatility

Is V67A's price volatile compared to industry and market?
V67A volatility
V67A Average Weekly Movement12.9%
Healthcare Industry Average Movement6.2%
Market Average Movement6.4%
10% most volatile stocks in DE Market12.9%
10% least volatile stocks in DE Market3.1%

Stable Share Price: V67A's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: V67A's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
2009149Greg Siokaswww.cosmosholdingsinc.com

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United States, Croatia, Bulgaria, Ireland, the Cayman Islands, the UAE, the United Kingdom, and Cyprus. The company offers medicines, OTC medicines, nutraceutical products, vitamins, minerals, and dietary health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin).

Cosmos Health Inc. Fundamentals Summary

How do Cosmos Health's earnings and revenue compare to its market cap?
V67A fundamental statistics
Market cap€10.68m
Earnings (TTM)-€19.78m
Revenue (TTM)€48.11m

0.2x

P/S Ratio

-0.5x

P/E Ratio

Is V67A overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
V67A income statement (TTM)
RevenueUS$54.43m
Cost of RevenueUS$50.12m
Gross ProfitUS$4.31m
Other ExpensesUS$26.69m
Earnings-US$22.38m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.82
Gross Margin7.92%
Net Profit Margin-41.12%
Debt/Equity Ratio45.3%

How did V67A perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/07 01:58
End of Day Share Price 2025/05/07 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cosmos Health Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Howard HalpernTaglich Brothers, Inc.